Mefenamic acid - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mefenamic acid and what is the scope of patent protection?
Mefenamic acid
is the generic ingredient in two branded drugs marketed by Belcher, Chartwell Rx, Lupin Ltd, Micro Labs, Nostrum Labs Inc, and Avion Pharms, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for mefenamic acid. Six suppliers are listed for this compound.
Summary for mefenamic acid
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 6 |
Drug Master File Entries: | 13 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 16 |
Patent Applications: | 6,768 |
Drug Prices: | Drug price trends for mefenamic acid |
What excipients (inactive ingredients) are in mefenamic acid? | mefenamic acid excipients list |
DailyMed Link: | mefenamic acid at DailyMed |
Recent Clinical Trials for mefenamic acid
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Takeda | Phase 1 |
Syneos Health | Phase 1 |
Nuventra | Phase 1 |
Pharmacology for mefenamic acid
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for mefenamic acid
Anatomical Therapeutic Chemical (ATC) Classes for mefenamic acid
US Patents and Regulatory Information for mefenamic acid
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 209209-001 | Sep 18, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Avion Pharms | PONSTEL | mefenamic acid | CAPSULE;ORAL | 015034-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lupin Ltd | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091322-001 | Jul 22, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Belcher | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091608-001 | Jun 2, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Nostrum Labs Inc | MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 090359-001 | Feb 5, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.